Bio-Rad Laboratories - 45 Year Stock Price History | BIO
Historical daily share price chart and data for Bio-Rad Laboratories since 1980 adjusted for splits and dividends. The latest closing stock price for Bio-Rad Laboratories as of June 17, 2025 is 230.46.
- The all-time high Bio-Rad Laboratories stock closing price was 825.77 on September 02, 2021.
- The Bio-Rad Laboratories 52-week high stock price is 387.99, which is 68.4% above the current share price.
- The Bio-Rad Laboratories 52-week low stock price is 211.43, which is 8.3% below the current share price.
- The average Bio-Rad Laboratories stock price for the last 52 weeks is 300.42.
| Bio-Rad Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 270.1274 | 326.1600 | 367.0000 | 216.5600 | 230.4600 | -29.85% |
| 2024 | 319.1788 | 327.9900 | 374.2800 | 263.9700 | 328.5100 | 1.74% |
| 2023 | 393.2294 | 422.4300 | 503.0000 | 269.3700 | 322.8900 | -23.21% |
| 2022 | 505.9841 | 735.4200 | 735.4200 | 351.7100 | 420.4900 | -44.35% |
| 2021 | 675.8090 | 575.2600 | 825.7700 | 547.0100 | 755.5700 | 29.61% |
| 2020 | 472.1816 | 372.1600 | 643.4500 | 320.0100 | 582.9400 | 57.54% |
| 2019 | 312.5641 | 228.0800 | 374.2000 | 224.3000 | 370.0300 | 59.34% |
| 2018 | 277.5328 | 241.4200 | 326.1500 | 220.1000 | 232.2200 | -2.70% |
| 2017 | 219.5758 | 182.9100 | 271.3000 | 182.9100 | 238.6700 | 30.94% |
| 2016 | 149.1690 | 136.1900 | 183.4600 | 123.9300 | 182.2800 | 31.46% |
| 2015 | 137.5260 | 120.3500 | 151.9300 | 113.7700 | 138.6600 | 15.01% |
| 2014 | 120.8765 | 122.6500 | 133.7300 | 106.4800 | 120.5600 | -2.47% |
| 2013 | 118.6682 | 107.4600 | 126.0000 | 107.4600 | 123.6100 | 17.67% |
| 2012 | 102.7218 | 98.0800 | 114.2500 | 92.3000 | 105.0500 | 9.38% |
| 2011 | 108.0200 | 105.3200 | 126.3400 | 87.5400 | 96.0400 | -7.52% |
| 2010 | 94.7088 | 97.8700 | 113.6300 | 81.5000 | 103.8500 | 7.66% |
| 2009 | 78.5782 | 74.4700 | 100.4600 | 53.1000 | 96.4600 | 28.08% |
| 2008 | 87.1254 | 99.9700 | 108.1000 | 61.5200 | 75.3100 | -27.32% |
| 2007 | 82.9541 | 82.2200 | 107.5700 | 67.6700 | 103.6200 | 25.57% |
| 2006 | 68.9380 | 65.4500 | 84.0100 | 57.2500 | 82.5200 | 26.10% |
| 2005 | 55.5089 | 57.1700 | 66.9000 | 47.0600 | 65.4400 | 14.07% |
| 2004 | 55.2252 | 58.4100 | 61.9000 | 50.0100 | 57.3700 | -0.52% |
| 2003 | 48.0377 | 38.2100 | 62.1500 | 33.4000 | 57.6700 | 49.02% |
| 2002 | 39.7467 | 30.9000 | 50.5100 | 28.1250 | 38.7000 | 22.27% |
| 2001 | 23.7924 | 16.0500 | 32.5250 | 15.0750 | 31.6500 | 99.06% |
| 2000 | 12.9793 | 11.3125 | 16.7450 | 10.6250 | 15.9000 | 36.04% |
| 1999 | 12.2612 | 10.3125 | 14.5000 | 9.4375 | 11.6875 | 11.31% |
| 1998 | 13.1470 | 13.0625 | 16.8750 | 9.8750 | 10.5000 | -19.62% |
| 1997 | 13.5673 | 15.1875 | 16.3750 | 11.8125 | 13.0625 | -12.92% |
| 1996 | 14.6823 | 14.2083 | 18.3125 | 12.1250 | 15.0000 | 5.88% |
| 1995 | 11.3629 | 9.1250 | 14.1667 | 8.4583 | 14.1667 | 53.15% |
| 1994 | 6.4239 | 3.5000 | 9.6250 | 3.5000 | 9.2500 | 177.50% |
| 1993 | 4.7749 | 5.7083 | 5.9167 | 3.3333 | 3.3333 | -41.61% |
| 1992 | 6.1821 | 6.4167 | 7.1250 | 5.3750 | 5.7083 | -13.29% |
| 1991 | 7.0525 | 6.0833 | 9.1667 | 5.5417 | 6.5833 | 6.76% |
| 1990 | 5.8093 | 5.4167 | 7.6667 | 4.2083 | 6.1667 | 15.63% |
| 1989 | 5.6551 | 5.7083 | 6.5417 | 4.7500 | 5.3333 | -5.88% |
| 1988 | 6.3804 | 5.2500 | 7.7083 | 4.9167 | 5.6667 | 11.48% |
| 1987 | 7.6194 | 5.8750 | 10.6667 | 3.7500 | 5.0833 | -11.59% |
| 1986 | 5.9523 | 5.0556 | 7.6389 | 4.5556 | 5.7500 | 13.74% |
| 1985 | 3.2332 | 2.1296 | 5.3056 | 2.1296 | 5.0556 | 137.40% |
| 1984 | 2.2030 | 2.5000 | 2.5185 | 2.0741 | 2.1296 | -14.82% |
| 1983 | 2.3316 | 1.3519 | 2.8704 | 1.3519 | 2.5000 | 87.50% |
| 1982 | 1.3125 | 1.5370 | 1.6111 | 0.8704 | 1.3333 | -7.69% |
| 1981 | 2.4658 | 2.9815 | 3.6667 | 1.2963 | 1.4444 | -51.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $6.175B | $2.567B |
| Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components. Bio-Rad has extensive and direct distribution channels outside the United States through subsidiaries which focus on sales, customer service and product distribution. The company operates through two reportable segments - Life Science segment which designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Clinical Diagnostics - This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.957B | 28.04 |
| Boston Scientific (BSX) | United States | $147.560B | 37.59 |
| Stryker (SYK) | United States | $144.011B | 30.10 |
| EssilorLuxottica (ESLOY) | France | $128.708B | 0.00 |
| Medtronic (MDT) | Ireland | $111.928B | 15.99 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.371B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.904B | 27.49 |
| ResMed (RMD) | United States | $36.560B | 27.72 |
| Agilent Technologies (A) | United States | $33.258B | 22.04 |
| GE HealthCare Technologies (GEHC) | United States | $33.082B | 15.84 |
| Terumo (TRUMY) | Japan | $26.680B | 34.37 |
| Insulet (PODD) | United States | $21.438B | 84.69 |
| Koninklijke Philips (PHG) | Netherlands | $21.384B | 15.43 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.060B | 11.71 |
| Baxter (BAX) | United States | $15.713B | 11.81 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.872B | 0.00 |
| Demant (WILYY) | Denmark | $9.377B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.385B | 13.58 |
| Prestige Consumer Healthcare (PBH) | United States | $4.149B | 18.47 |
| Perrigo (PRGO) | Ireland | $3.664B | 9.30 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.367B | 15.31 |
| ICU Medical (ICUI) | United States | $3.250B | 24.18 |
| Envista Holdings (NVST) | United States | $3.127B | 26.73 |
| GN Store Nord (GNNDY) | Denmark | $2.263B | 19.32 |
| QuidelOrtho (QDEL) | United States | $1.954B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.833B | 41.46 |
| AtriCure (ATRC) | United States | $1.565B | 0.00 |
| Acuren (TIC) | United States | $1.357B | 0.00 |
| Neogen (NEOG) | United States | $1.200B | 15.67 |
| AdaptHealth (AHCO) | United States | $1.161B | 11.81 |
| Green Thumb Industries (GTBIF) | United States | $1.048B | 23.71 |
| BioLife Solutions (BLFS) | United States | $1.046B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.970B | 12.80 |
| Kestra Medical Technologies (KMTS) | United States | $0.904B | 0.00 |
| InMode (INMD) | Israel | $0.844B | 8.55 |
| Evolus (EOLS) | United States | $0.640B | 0.00 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Owens & Minor (OMI) | United States | $0.602B | 5.08 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.538B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.524B | 0.00 |
| Valneva SE (VALN) | France | $0.510B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.407B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.337B | 12.53 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.329B | 61.50 |
| Canopy Growth (CGC) | Canada | $0.272B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.263B | 22.50 |
| Sanara MedTech (SMTI) | United States | $0.256B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.253B | 11.63 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.245B | 0.00 |
| Quanterix (QTRX) | United States | $0.235B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.207B | 6.12 |
| Brainsway (BWAY) | Israel | $0.206B | 55.30 |
| Omeros (OMER) | United States | $0.199B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.187B | 0.00 |
| High Tide (HITI) | Canada | $0.185B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.179B | 14.57 |
| Verano Holdings (VRNOF) | United States | $0.174B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.140B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 15.33 |
| Jin Medical (ZJYL) | China | $0.107B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.37 |
| Veru (VERU) | United States | $0.090B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.087B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.087B | 0.00 |
| Agape ATP (ATPC) | $0.084B | 0.00 | |
| TerrAscend (TSNDF) | Canada | $0.075B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Apyx Medical (APYX) | United States | $0.066B | 0.00 |
| Zynex (ZYXI) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.042B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 48.64 |
| United-Guardian (UG) | United States | $0.037B | 13.19 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| INLIF (INLF) | $0.012B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |